BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 26289219)

  • 1. Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.
    Xu SS; Wu J; Jiang W
    J Microencapsul; 2015; 32(6):533-7. PubMed ID: 26289219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
    Wu J; Jiang W; Shen Y; Jiang W; Tian R
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
    Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
    Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characteristics of Fe3O4 magnetic nanocomposites based on Poly(N-isopropylacrylamide) for anti-cancer drug delivery.
    Davaran S; Alimirzalu S; Nejati-Koshki K; Nasrabadi HT; Akbarzadeh A; Khandaghi AA; Abbasian M; Alimohammadi S
    Asian Pac J Cancer Prev; 2014; 15(1):49-54. PubMed ID: 24528080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of stimuli-responsive chitosan nanocomposites via RAFT copolymerization for doxorubicin delivery.
    Hosseinzadeh S; Hosseinzadeh H; Pashaei S; Khodaparast Z
    Int J Biol Macromol; 2019 Jan; 121():677-685. PubMed ID: 30339997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
    Kaamyabi S; Badrian A; Akbarzadeh A
    Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
    Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
    J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.
    Sadighian S; Rostamizadeh K; Hosseini-Monfared H; Hamidi M
    Colloids Surf B Biointerfaces; 2014 May; 117():406-13. PubMed ID: 24675279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of magnetic silica with thermoresponsive chitosan coating for drug controlled release and magnetic hyperthermia application.
    Pon-On W; Tithito T; Maneeprakorn W; Phenrat T; Tang IM
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():23-30. PubMed ID: 30678907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
    Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery.
    Du C; Deng D; Shan L; Wan S; Cao J; Tian J; Achilefu S; Gu Y
    Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe
    Gerami SE; Pourmadadi M; Fatoorehchi H; Yazdian F; Rashedi H; Nigjeh MN
    Int J Biol Macromol; 2021 Mar; 173():409-420. PubMed ID: 33454326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system.
    Barahuie F; Dorniani D; Saifullah B; Gothai S; Hussein MZ; Pandurangan AK; Arulselvan P; Norhaizan ME
    Int J Nanomedicine; 2017; 12():2361-2372. PubMed ID: 28392693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetically guided release of ciprofloxacin from superparamagnetic polymer nanocomposites.
    Gupta R; Bajpai AK
    J Biomater Sci Polym Ed; 2011; 22(7):893-918. PubMed ID: 20566063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of carboxymethyl chitosan/Fe
    Naderi Z; Azizian J
    J Photochem Photobiol B; 2018 Aug; 185():206-214. PubMed ID: 29966987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
    Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
    Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and properties of hybrid monodispersed magnetic α-Fe2O3 based chitosan nanocomposite film for industrial and biomedical applications.
    Singh J; Srivastava M; Dutta J; Dutta PK
    Int J Biol Macromol; 2011 Jan; 48(1):170-6. PubMed ID: 21056054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.